首页> 外文期刊>Cytopathology >Dipeptidyl peptidase IV expression in thyroid cytology: retrospective histologically confirmed study.
【24h】

Dipeptidyl peptidase IV expression in thyroid cytology: retrospective histologically confirmed study.

机译:甲状腺细胞学中的二肽基肽酶IV表达:回顾性组织学证实的研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Fine needle aspiration cytology (FNAC) of the thyroid gland is a well-established method. However, it has inherent limitations, especially in the diagnosis of follicular and oncocytic tumours and in distinguishing between nuclear atypia in colloid goitre with regressive changes and cystic papillary carcinoma. The aim of our study was to evaluate dipeptidyl peptidase IV (DPP IV) as a marker of malignancy in FNAC. We tested 254 thyroid specimens (intraoperative imprint smears) for DPP IV. The sensitivity was 71%, the specificity was 96%, and the diagnostic accuracy was 93%, respectively, with a threshold of 50% of positive cells. To the best of our knowledge it is the largest histologically confirmed study reported in the literature. We suggest the assessment of DPP IV as an adjunct diagnostic marker of malignancy in thyroid specimens suspicious of papillary carcinoma. However, the value of the marker in follicular lesions is very limited.
机译:甲状腺细针穿刺细胞学检查(FNAC)是一种公认​​的方法。然而,它具有固有的局限性,特别是在滤泡性和肿瘤性肿瘤的诊断以及区分具有退行性改变的胶体甲状腺肿中的核型非典型性和囊性乳头状癌方面。我们研究的目的是评估二肽基肽酶IV(DPP IV)作为FNAC中恶性肿瘤的标志物。我们测试了254个甲状腺标本(术中烙印涂片)的DPP IV。灵敏度为71%,特异性为96%,诊断准确性为93%,阈值为阳性细胞的50%。据我们所知,这是文献中报道的最大的组织学证实的研究。我们建议对可疑乳头状癌的甲状腺标本中DPP IV作为恶性肿瘤的辅助诊断标记进行评估。但是,标记在卵泡病变中的价值非常有限。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号